Descovy (emtricitabine/tenofovir alafenamide)

emtricitabine/tenofovir alafenamide · Gilead Sciences

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Descovy (emtricitabine/tenofovir alafenamide), covering 2024-11-25 to 2026-02-03. Get the full timeline:

Most recent: Clinical Trial Update: CARE: Comprehensive Assessment of Real-world Effectiveness of F/TAF in Persons Who Use Drugs (PWUD)